DAGLA
Basic information
Region (hg38): 11:61680391-61747001
Previous symbols: [ "C11orf11" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Benign paroxysmal tonic upgaze of childhood with ataxia (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAGLA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 16 | ||||
missense | 36 | 43 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 1 | |||||
Total | 1 | 2 | 37 | 14 | 10 |
Variants in DAGLA
This is a list of pathogenic ClinVar variants found in the DAGLA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-61720167-C-T | DAGLA-related disorder | Likely benign (Jan 10, 2020) | ||
11-61720218-G-A | DAGLA-related disorder | Benign (Oct 17, 2019) | ||
11-61720679-G-A | Uncertain significance (Jan 10, 2024) | |||
11-61720707-G-A | Inborn genetic diseases | Uncertain significance (Jul 10, 2023) | ||
11-61720744-A-G | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
11-61720749-G-A | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
11-61720762-G-A | Inborn genetic diseases | Uncertain significance (Jun 26, 2024) | ||
11-61720792-T-C | Inborn genetic diseases | Uncertain significance (Jun 25, 2024) | ||
11-61720824-A-G | Uncertain significance (Mar 28, 2024) | |||
11-61720829-C-T | DAGLA-related disorder | Likely benign (Jun 13, 2019) | ||
11-61722931-A-G | DAGLA-related disorder | Uncertain significance (Dec 01, 2023) | ||
11-61723430-G-A | DAGLA-related disorder | Likely benign (Aug 19, 2019) | ||
11-61723495-C-T | Benign (Apr 03, 2018) | |||
11-61728163-C-G | Autism | Uncertain significance (-) | ||
11-61728259-G-A | Inborn genetic diseases | Uncertain significance (May 18, 2022) | ||
11-61728273-G-A | Inborn genetic diseases | Uncertain significance (Aug 08, 2023) | ||
11-61728285-G-A | Inborn genetic diseases | Uncertain significance (Oct 30, 2023) | ||
11-61728939-T-C | Likely benign (Mar 29, 2018) | |||
11-61728994-G-A | Inborn genetic diseases | Uncertain significance (Sep 10, 2024) | ||
11-61731323-A-T | DAGLA-related disorder | Uncertain significance (Dec 27, 2023) | ||
11-61731348-A-G | Uncertain significance (Dec 06, 2022) | |||
11-61731402-A-G | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
11-61734872-C-T | DAGLA-related disorder | Uncertain significance (Jul 08, 2024) | ||
11-61734879-C-T | DAGLA-related disorder | Benign (May 09, 2018) | ||
11-61734895-A-G | Inborn genetic diseases | Uncertain significance (Dec 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DAGLA | protein_coding | protein_coding | ENST00000257215 | 19 | 66569 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000105 | 125735 | 0 | 7 | 125742 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.01 | 402 | 700 | 0.574 | 0.0000494 | 6687 |
Missense in Polyphen | 136 | 328.41 | 0.41412 | 3149 | ||
Synonymous | -0.0920 | 317 | 315 | 1.01 | 0.0000237 | 2217 |
Loss of Function | 5.83 | 3 | 45.4 | 0.0660 | 0.00000213 | 505 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000451 | 0.0000439 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of diacylglycerol (DAG) to 2- arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. {ECO:0000269|PubMed:14610053}.;
- Pathway
- Aldosterone synthesis and secretion - Homo sapiens (human);Retrograde endocannabinoid signaling - Homo sapiens (human);Cell-type Dependent Selectivity of CCK2R Signaling;Cannabinoid receptor signaling;Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Arachidonate production from DAG;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling;N-cadherin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.120
Intolerance Scores
- loftool
- 0.141
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.96
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.369
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dagla
- Phenotype
- normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- dagla
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- G protein-coupled glutamate receptor signaling pathway;neuroblast proliferation;arachidonic acid metabolic process;neurogenesis;neurotransmitter biosynthetic process;diacylglycerol catabolic process;endocannabinoid signaling pathway;retrograde trans-synaptic signaling by endocannabinoid
- Cellular component
- plasma membrane;varicosity;postsynaptic membrane;integral component of postsynaptic membrane
- Molecular function
- metal ion binding;acylglycerol lipase activity